China Universal Asset Management »

Larimar Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $49k 15k 3.23
2025-06-30 $37k 13k 2.89
2025-03-31 $28k 13k 2.15
2024-12-31 $52k 14k 3.87
2022-09-30 $999 165 6.06

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Larimar Therapeutics

Deerfield Management Company
RA Capital Management
Blue Owl Capital Holdings
Millennium Management
Opaleye Management
BlackRock
Rtw Investments
Vanguard Group
Caption Management
Logos Global Management
Adage Capital Partners GP
Alyeska Investment Group
Citadel Advisors
Woodline Partners
Goldman Sachs Group

View all funds holding Larimar Therapeutics